Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 127311000087117 | somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | fr | Fully specified name | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 323381000077111 | somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 3690000018 | Product containing precisely somatropin(rbe) 5.3 milligram/1 cartridge powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3690001019 | Somatropin(rbe) 5.3 mg powder for solution for injection cartridge | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | est un(e) (attribut) | Product containing only somatropin(rbe) in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | est un(e) (attribut) | Product containing somatropin (medicinal product) | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | a pour principe actif (attribut) | Somatropin(rbe) (substance) | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | a pour principe actif (attribut) | Anterior pituitary hormone | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | a pour principe actif (attribut) | Pituitary hormone | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | a une forme pharmaceutique (attribut) | Injection | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | a une forme pharmaceutique (attribut) | Powder for solution for injection | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | a pour principe actif (attribut) | Human growth hormone recombinant (product) | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | est un(e) (attribut) | Somatropin-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | Has unit of presentation | Cartridge (unit of presentation) | false | Inferred relationship | Some | ||
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | Has presentation strength numerator value (attribute) | 5.3 (qualifier value) | false | Inferred relationship | Some | 1 | |
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | Has precise active ingredient | Somatropin(rbe) (substance) | false | Inferred relationship | Some | 1 | |
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | Has presentation strength denominator unit (attribute) | Cartridge (unit of presentation) | false | Inferred relationship | Some | 1 | |
| somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable (médicament clinique) | Has basis of strength substance (attribute) | Somatropin(rbe) (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
MOVED TO association reference set
FHIR